Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 18;23:514. doi: 10.1186/s12888-023-05014-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

PMC Copyright notice

Fig. 4 — Effects of minocycline and antipsychotics on OX42 marker of microglia activated by LPS. The cells were randomly divided into 5 groups. The blank control group (A) was treated with nothing, the LPS group (B) was treated with 1.0 ug/ml LPS for 24 h. The three drug groups were pretreated with 10 μmol/L minocycline (C), 10 μmol/L risperidone (D) and 50 μmol/L haloperidol (E) respectively for 24 h, and then 1.0 ug/ml LPS was added for 24 h. The changes of microglia specific marker OX-42 were observed by immunofluorescence. Each group chose one of the three separate images as a representative. Scale bar in Fig.A is 15 μm, in Fig.B-E is 25 μm. The bar chart (F) shows statistical results of MFI. ^###p < 0.001 was compared with the blank control group; *p < 0.05, **p < 0.01, and ***p < 0.001 were compared with the LPS group.